Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral AI Inc MDAI

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.


NDAQ:MDAI - Post by User

Post by anthonysolle1on Jan 30, 2024 5:57am
1109 Views
Post# 35852046

$MDAI's Innovative Wound Care Solutions

$MDAI's Innovative Wound Care Solutions$MDAI prioritizes medical diagnostics, with a particular focus on advancing wound care management strategies. By targeting critical issues such as burns and diabetic foot ulcers, the company aims to introduce innovative technologies that optimize diagnostic accuracy and facilitate more effective treatment interventions. $MDAI experienced a significant boost in trading volume, totaling 13 million+ shares on the previous trading day. This surge underscores increasing investor confidence in $MDAI's ability to revolutionize the field of medical diagnostics.

Know more: https://tinyurl.com/yc58yz2r
<< Previous
Bullboard Posts
Next >>